LIMN compared with BURU: revenue, margins and what each company keeps, and the suppliers and customers both name

LIMNLiminatus Pharma, Inc.

Mkt capRevenueRevenue

BURUNuburu, Inc.

Mkt capRevenueRevenue

Compare

LIMNLiminatus Pharma, Inc.

BURUNuburu, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LIMNLiminatus Pharma, Inc.

2.66▲+5.56%

Mkt cap$2.4MRevenue—

BURUNuburu, Inc.

0.27▲+8.67%

Regular sessionNov 3 '26

Mkt cap$1.3MRevenue$524,927Q2 FY26

Compare

Regular sessionNov 3 '26

LIMNLiminatus Pharma, Inc.

BURUNuburu, Inc.

2.66▲+5.56%

Price

0.27▲+8.67%

$2.4M

Mkt cap

$1.3M

—

Revenue

$524,927Q2 FY26

LIMN2.66▲+5.56%vsBURU0.27▲+8.67%Regular sessionNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

LIMN: latest quarter not drawable. BURU: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LIMN 0

None

Shared 0

No disclosed counterparties: LIMN.

Only BURU 5

—Undisclosed customerunlistedcustomer

—Orbit S.r.lunlistedsupplier

—Tceiunlistedsupplier

—Tekneunlistedsupplier

1 more · BURU chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

LIMN, solidBURU, dashed